March 16, 2015 8:06 AM | 1 min read |
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
(NASDAQ: MVIS) shares surged 20.44% to $3.30 in pre-market trading following the announcement of $14.5 million in component orders.
Amarin Corporation plc (NASDAQ: AMRN) gained 8.97% to $3.16 in pre-market trading after surging 21.85% on Friday.
CTI BioPharma Corp.(NASDAQ: CTIC) shares gained 5.58% to $2.08 in the pre-market trading session after the company reported positive results in blood of Phase 2 results of pacritinib in patients with myelofibrosis.
Boston Scientific Corporation (NYSE: BSX) shares rose 2.71% to $17.06 in pre-market trading after the company received the FDA approval for WATCHMAN left atrial appendage closure device.
Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) shares climbed 1.53% to $172.00 in pre-market trading.
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) and Salix have agreed on an amended $173 per share in cash deal.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.